Small Molecule Immuno-Oncology Compound Library

Réf. Cat.L4800

Une collection unique de 262 Immuno-Oncology small molecules utilisées pour l'oncothérapie en conjonction avec d'autres médicaments.

96 well plates

Personnalisez votre bibliothèque:

Cité par 322 Publications

Description & Avantages

• A unique collection of 262 Immuno-Oncology small molecules for high throughput screening(HTS) and high content screening (HCS)
 
• Target includes PD-1/PD-L1, IDOCCRCXCRTLRHER2STAT3, etc.
 
• A useful tool for finding tumor therapeutic mechanism
 
• For studying human diseases, exploring the pathogenesis of diseases
such as cancer, and opening noval therapeutic ways
 
• Structurally diverse, medicinally active, and cell permeable
 
• Rich documentation with structure description, target information, IC50
 values and customer reviews
 
• NMR and HPLC validated to ensure high purity

 

Détails du produit

Formulation 237 compounds pre-dissolved in 10mM DMSO, 13 compounds pre-dissolved in 10mM water, 11 compounds pre-dissolved in 2mM DMSO and 1 compound pre-dissolved in 2mM water
Conteneur Plaque à 96 puits profonds scellée avec du papier daluminium
Stabilité 12 months -20°C in DMSO
24 months -80°C in DMSO
Expédition Glace bleue ou glace sèche

Études de cas utilisant les bibliothèques de composés Selleck

Small Molecule Immuno-Oncology Compound Library Composition

Partenaires de linstallation HTS

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania